Fluconazole 200 mg suppositories are solid dosage forms designed for insertion into a body cavity, typically the vagina, where they dissolve or melt to release medication for local absorption. Fluconazole is an antifungal agent belonging to the triazole class, which works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. This disruption leads to increased cellular permeability and ultimately the death of the fungal cell.

This formulation is primarily used for the treatment of vaginal yeast infections caused by Candida species. By delivering the medication directly to the site of infection, the suppository form can provide targeted antifungal activity, potentially reducing systemic side effects associated with oral therapy. The 200 mg dosage ensures a sufficient concentration of the drug to combat fungal growth effectively.

For patients, using fluconazole suppositories may alleviate symptoms such as itching, burning, and abnormal discharge associated with vaginal candidiasis. The local application allows for rapid symptom relief and may be especially beneficial for individuals who experience gastrointestinal side effects from oral antifungal medications. It is important for patients to follow the prescribed treatment regimen and complete the full course of therapy to prevent recurrence of the infection.

Prescribers may consider fluconazole 200 mg suppositories for patients who prefer a local treatment option or when oral administration is contraindicated. This formulation can be particularly useful in cases of recurrent or resistant infections where higher localized concentrations of the drug are desired. Additionally, the suppository form bypasses hepatic first-pass metabolism, which can be advantageous in reducing systemic exposure and potential drug interactions.

While generally well-tolerated, some patients may experience local adverse effects such as irritation or discomfort at the application site. It is advisable to counsel patients on the proper insertion technique and to inform them to report any severe or persistent side effects. Monitoring for signs of hypersensitivity reactions is also recommended, although such occurrences are rare.

If you have any questions, please reach out to us.

Fluconazole 200 mg suppositories are a solid dosage form designed for insertion into a body cavity, typically the rectum or vagina, where they dissolve or melt to release medication for local or systemic absorption. This formulation is primarily used to treat fungal infections, such as vaginal yeast infections, and may also be used for other fungal infections as determined by a healthcare provider. While fluconazole is effective in treating these conditions, it is important to be aware of potential drug interactions that could affect its efficacy or increase the risk of adverse effects.

Fluconazole is a potent inhibitor of the cytochrome P450 enzyme CYP3A4, as well as CYP2C9 and CYP2C19. This means that it can interact with a wide range of medications that are metabolized by these enzymes, potentially leading to increased blood levels and enhanced effects or toxicity of these drugs. Patients and prescribers should be particularly cautious when fluconazole is used concurrently with medications such as warfarin, as this can increase the risk of bleeding due to elevated INR levels. Regular monitoring of INR is recommended in such cases.

Another significant interaction is with certain statins, such as simvastatin and atorvastatin, where fluconazole can increase the risk of muscle-related side effects, including rhabdomyolysis. It is advisable to consider alternative lipid-lowering therapies or adjust the statin dose while using fluconazole. Additionally, fluconazole can increase the levels of certain benzodiazepines, such as midazolam and triazolam, leading to enhanced sedative effects. Dose adjustments or alternative anxiolytics may be necessary.

Fluconazole may also interact with oral hypoglycemic agents, such as sulfonylureas, leading to an increased risk of hypoglycemia. Patients should be advised to monitor their blood glucose levels closely and adjust their diabetes medications as needed. Furthermore, fluconazole can increase the plasma concentrations of certain antiepileptic drugs, such as phenytoin, necessitating careful monitoring of drug levels and potential dose adjustments to avoid toxicity.

Patients taking fluconazole suppositories should also be aware of potential interactions with other antifungal agents, as concurrent use may lead to additive effects or increased side effects. It is important to inform healthcare providers of all medications, including over-the-counter drugs and supplements, to assess for potential interactions. If you have any questions or concerns about drug interactions with fluconazole 200 mg suppositories, please reach out to us for further guidance and support.

Fluconazole 200 mg suppositories are a specialized formulation designed to deliver the antifungal medication fluconazole directly to the site of infection or for systemic absorption through mucosal tissues. This solid dosage form is intended for insertion into a body cavity, typically the rectum or vagina, where it dissolves or melts at body temperature. Upon insertion, the suppository base, often composed of substances like polyethylene glycol or cocoa butter, begins to dissolve or melt, facilitating the release of fluconazole.

Fluconazole is an antifungal agent that belongs to the triazole class of medications. It works by inhibiting the synthesis of ergosterol, a critical component of fungal cell membranes. By disrupting the production of ergosterol, fluconazole compromises the integrity of the fungal cell membrane, leading to cell death and the resolution of the infection. This mechanism of action makes fluconazole effective against a variety of fungal pathogens, including Candida species, which are commonly responsible for infections such as vaginal yeast infections and systemic candidiasis.

When administered as a suppository, fluconazole can provide both local and systemic effects. In the case of vaginal administration, the medication is delivered directly to the site of infection, allowing for high local concentrations that can effectively eradicate fungal cells. This localized delivery is particularly beneficial for treating vaginal yeast infections, as it minimizes systemic exposure and potential side effects. For rectal administration, the suppository can facilitate systemic absorption through the rectal mucosa, providing an alternative route for patients who may have difficulty swallowing oral medications or require rapid systemic effects.

Fluconazole 200 mg suppositories offer a convenient and effective treatment option for patients with fungal infections, particularly when oral administration is not feasible or when localized treatment is preferred. This formulation is especially useful for patients with recurrent or resistant infections, as it allows for targeted delivery of the medication. Prescribers may consider this formulation for patients who require a tailored approach to antifungal therapy, taking into account the specific needs and circumstances of each patient.

For both patients and prescribers, it is important to follow the prescribed dosing regimen and administration instructions to ensure optimal therapeutic outcomes. Patients should be advised on the proper insertion technique and the importance of completing the full course of treatment, even if symptoms improve before the medication is finished. As with any medication, potential side effects and interactions should be discussed with a healthcare provider.

If you have any questions or need further information about fluconazole 200 mg suppositories, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or concerns you may have regarding this formulation or its use in treating fungal infections.

Fluconazole 200 mg suppositories are primarily used for the treatment of fungal infections, particularly those affecting the vaginal or rectal areas. However, beyond their primary indications, these suppositories may have other potential uses that could be beneficial for both patients and prescribers to consider. One such use is in the management of systemic fungal infections in patients who may have difficulty swallowing oral medications or in those who experience gastrointestinal side effects from oral antifungal therapies. The suppository form allows for the medication to be absorbed through the mucosal lining, providing an alternative route for systemic absorption.

Additionally, fluconazole suppositories may be considered for off-label use in the treatment of fungal infections in other body cavities, such as the oral cavity, in patients who are unable to tolerate topical or oral treatments. This could be particularly useful in immunocompromised patients who are at higher risk for opportunistic fungal infections and require a more localized treatment approach. Furthermore, the use of fluconazole suppositories might be explored in the context of prophylactic treatment for patients undergoing chemotherapy or other immunosuppressive therapies, where the risk of fungal infections is significantly increased.

For prescribers, it is important to consider the patient's overall health status, potential drug interactions, and the specific fungal pathogen involved when contemplating the use of fluconazole suppositories for off-label purposes. Patients should be informed about the potential benefits and risks associated with this form of treatment, including the possibility of local irritation or discomfort upon insertion. As with any medication, adherence to prescribed dosing and duration of therapy is crucial to ensure efficacy and minimize the risk of resistance. If you have any questions or need further information about the use of fluconazole 200 mg suppositories, please reach out to us at Bayview Pharmacy.